Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report

Int J Infect Dis. 2020 Apr:93:297-299. doi: 10.1016/j.ijid.2020.03.003. Epub 2020 Mar 5.

Authors

Dabiao Chen¹, Wenxiong Xu¹, Ziying Lei¹, Zhanlian Huang¹, Jing Liu¹, Zhiliang Gao¹, Liang Peng²

Affiliations

¹ Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong, China; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong, China.
² Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong, China; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong, China. Electronic address: pliang@mail.sysu.edu.cn.

Abstract

The ongoing outbreak of COVID-19 that began in Wuhan, China, has constituted a Public Health Emergency of International Concern, with cases confirmed in multiple countries. Currently, patients are the primary source of infection. We report a confirmed case of COVID-19 whose oropharyngeal swab test of SARS-CoV-2 RNA turned positive in convalescence. This case highlights the importance of active surveillance of SARS-CoV-2 RNA for infectivity assessment.

Keywords: COVID-19; Infectivity; NCP; Novel coronavirus; SARS-CoV-2.

Publication types

Case Reports

MeSH terms

Betacoronavirus / physiology*
COVID-19
China / epidemiology
Coronavirus Infections / diagnosis*
Coronavirus Infections / virology*
Diagnostic Tests, Routine / standards
Disease Outbreaks
Disease Progression
Female
Humans
Middle Aged
Pandemics*
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / virology*
Public Health
RNA, Viral* / isolation & purification
Recurrence
SARS-CoV-2
Time

Substances

RNA, Viral